Literature DB >> 17627285

Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression.

D C Phillips1, J T Hunt, C G Moneypenny, K H Maclean, P P McKenzie, L C Harris, J A Houghton.   

Abstract

The sphingoplipid ceramide is responsible for a diverse range of biochemical and cellular responses including a putative role in modulating cell cycle progression. Herein, we describe that an accumulation of ceramide, achieved through the exogenous application of C(6)-ceramide or exposure to sphingomyelinase, induces a G(2) arrest in Rhabdomyosarcoma (RMS) cell lines. Utilizing the RMS cell line RD, we show that this G(2) arrest required the rapid induction of p21(Cip1/Waf1) independent of DNA damage. This was followed at later time points (48 h) by the commitment to apoptosis. Apoptosis was prevented by Bcl-2 overexpression, but permitted the maintenance of elevated p21(Cip1/Waf1) protein expression and the stabilization of the G(2) arrest response. Inhibition of p21(Cip1/Waf1) protein synthesis with cyclohexamide (CHX) or silencing of p21(Cip1/Waf1) with siRNA, prevented ceramide-mediated G(2) arrest and the late induction of apoptosis. Further, adopting the recent discovery that murine double minute 2 (MDM2) controls p21(Cip1/Waf1) expression by presenting this CDK inhibitor to the proteasome for degradation, RD cells overexpressing MDM2 abrogated ceramide-mediated p21(Cip1/Waf1) induction, G(2) arrest and the late ensuing apoptosis. Collectively, these data further support the notion that ceramide accumulation can modulate cell cycle progression. Additionally, these observations highlight MDM2 expression and proteasomal activity as key determinants of the cellular response to ceramide accumulation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627285     DOI: 10.1038/sj.cdd.4402198

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  11 in total

Review 1.  Sphingolipids and expression regulation of genes in cancer.

Authors:  Gauri A Patwardhan; Yong-Yu Liu
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

Review 2.  Sphingolipids in the DNA damage response.

Authors:  Brittany Carroll; Jane Catalina Donaldson; Lina Obeid
Journal:  Adv Biol Regul       Date:  2014-11-18

Review 3.  Cancer treatment strategies targeting sphingolipid metabolism.

Authors:  Babak Oskouian; Julie D Saba
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 4.  Ceramide-orchestrated signalling in cancer cells.

Authors:  Samy A F Morad; Myles C Cabot
Journal:  Nat Rev Cancer       Date:  2012-12-13       Impact factor: 60.716

5.  The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells.

Authors:  Zeynep Cakir; Guray Saydam; Fahri Sahin; Yusuf Baran
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-18       Impact factor: 4.553

Review 6.  Implications of Sphingolipids on Aging and Age-Related Diseases.

Authors:  Shengxin Li; Hyun-Eui Kim
Journal:  Front Aging       Date:  2022-03-03

7.  Ceramide--antiestrogen nanoliposomal combinations--novel impact of hormonal therapy in hormone-insensitive breast cancer.

Authors:  Samy A F Morad; Jonathan C Levin; Sriram S Shanmugavelandy; Mark Kester; Gemma Fabrias; Carmen Bedia; Myles C Cabot
Journal:  Mol Cancer Ther       Date:  2012-09-07       Impact factor: 6.261

8.  Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis.

Authors:  Wei Hu; Ruijuan Xu; Wei Sun; Zdzislaw M Szulc; Jacek Bielawski; Lina M Obeid; Cungui Mao
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

Review 9.  Modulation of DNA Damage Response by Sphingolipid Signaling: An Interplay that Shapes Cell Fate.

Authors:  Marina Francis; Alaa Abou Daher; Patrick Azzam; Manal Mroueh; Youssef H Zeidan
Journal:  Int J Mol Sci       Date:  2020-06-24       Impact factor: 5.923

10.  Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.

Authors:  Meiling Zhang; Jamie Truscott; Judith Davie
Journal:  Mol Cancer       Date:  2013-11-27       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.